biocon: Biocon acquires Eywa Pharma's US-based plant for $7.7 million
Biocon Limited announced that its wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.s oral solid dosage manufacturing facility, located in Cranbury, New Jersey, U.S., effective from September 1, 2023.
Siddharth Mittal Healthcare Management Analytics Programme Indian School Of Business Biocon Generics Inc Drug Administration Offering College
Source: indiatimes.com